230 related articles for article (PubMed ID: 9787178)
1. Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Marti HH; Plate KH
Blood; 1998 Nov; 92(9):3388-93. PubMed ID: 9787178
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
3. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein.
Siemeister G; Weindel K; Mohrs K; Barleon B; Martiny-Baron G; Marmé D
Cancer Res; 1996 May; 56(10):2299-301. PubMed ID: 8625303
[TBL] [Abstract][Full Text] [Related]
4. Pathology, genetics and cell biology of hemangioblastomas.
Wizigmann-Voos S; Plate KH
Histol Histopathol; 1996 Oct; 11(4):1049-61. PubMed ID: 8930647
[TBL] [Abstract][Full Text] [Related]
5. Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene.
Stratmann R; Krieg M; Haas R; Plate KH
J Neuropathol Exp Neurol; 1997 Nov; 56(11):1242-52. PubMed ID: 9370235
[TBL] [Abstract][Full Text] [Related]
6. Von Hippel-Lindau disease.
Sano T; Horiguchi H
Microsc Res Tech; 2003 Feb; 60(2):159-64. PubMed ID: 12539169
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas.
Wizigmann-Voos S; Breier G; Risau W; Plate KH
Cancer Res; 1995 Mar; 55(6):1358-64. PubMed ID: 7533661
[TBL] [Abstract][Full Text] [Related]
8. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor.
Zagzag D; Krishnamachary B; Yee H; Okuyama H; Chiriboga L; Ali MA; Melamed J; Semenza GL
Cancer Res; 2005 Jul; 65(14):6178-88. PubMed ID: 16024619
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease.
Liang X; Shen D; Huang Y; Yin C; Bojanowski CM; Zhuang Z; Chan CC
Ophthalmology; 2007 Jan; 114(1):147-56. PubMed ID: 17070589
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological study of vascular endothelial growth factor (VEGF), p53, and proliferative potential in familial von Hippel-Lindau disease and sporadic hemangioblastomas.
Miyagami M; Katayama Y; Nakamura S
Brain Tumor Pathol; 2000; 17(3):111-20. PubMed ID: 11310918
[TBL] [Abstract][Full Text] [Related]
11. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.
Na X; Wu G; Ryan CK; Schoen SR; di'Santagnese PA; Messing EM
J Urol; 2003 Aug; 170(2 Pt 1):588-92. PubMed ID: 12853836
[TBL] [Abstract][Full Text] [Related]
12. von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease.
Vortmeyer AO; Gnarra JR; Emmert-Buck MR; Katz D; Linehan WM; Oldfield EH; Zhuang Z
Hum Pathol; 1997 May; 28(5):540-3. PubMed ID: 9158701
[TBL] [Abstract][Full Text] [Related]
13. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
14. The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity.
Mukhopadhyay D; Knebelmann B; Cohen HT; Ananth S; Sukhatme VP
Mol Cell Biol; 1997 Sep; 17(9):5629-39. PubMed ID: 9271438
[TBL] [Abstract][Full Text] [Related]
15. Inverse regulation of vascular endothelial growth factor and VHL tumor suppressor gene in sporadic renal cell carcinomas is correlated with vascular growth: an in vivo study on 29 tumors.
Brieger J; Weidt EJ; Schirmacher P; Störkel S; Huber C; Decker HJ
J Mol Med (Berl); 1999 Jun; 77(6):505-10. PubMed ID: 10475065
[TBL] [Abstract][Full Text] [Related]
16. VHL gene deletion and enhanced VEGF gene expression detected in the stromal cells of retinal angioma.
Chan CC; Vortmeyer AO; Chew EY; Green WR; Matteson DM; Shen DF; Linehan WM; Lubensky IA; Zhuang Z
Arch Ophthalmol; 1999 May; 117(5):625-30. PubMed ID: 10326959
[TBL] [Abstract][Full Text] [Related]
17. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
Wiesener MS; Münchenhagen PM; Berger I; Morgan NV; Roigas J; Schwiertz A; Jürgensen JS; Gruber G; Maxwell PH; Löning SA; Frei U; Maher ER; Gröne HJ; Eckardt KU
Cancer Res; 2001 Jul; 61(13):5215-22. PubMed ID: 11431362
[TBL] [Abstract][Full Text] [Related]
18. Von hippel-lindau disease: a genetic and clinical review.
Haddad NM; Cavallerano JD; Silva PS
Semin Ophthalmol; 2013; 28(5-6):377-86. PubMed ID: 24138046
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein.
Levy AP; Levy NS; Goldberg MA
J Biol Chem; 1996 Oct; 271(41):25492-7. PubMed ID: 8810320
[TBL] [Abstract][Full Text] [Related]
20. Regulation of vascular endothelial growth factor by hypoxia and its modulation by the von Hippel-Lindau tumor suppressor gene.
Levy AP; Levy NS; Iliopoulos O; Jiang C; Kaplin WG; Goldberg MA
Kidney Int; 1997 Feb; 51(2):575-8. PubMed ID: 9027742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
